Nasal vaccines may be the next generation of protection against COVID

CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing

Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival

Scientific Consortium Established by National Institutes of Health Provides Real-Time Risk Assessment of SARS-CoV-2 Variants on Immune Protection

Could mRNA Technology Revolutionize Future Vaccines and Treatments?

Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense

"You're going to need more than one coronavirus shot. One dose of a vaccine probably won't be enough, experts say." - Aylin Woodward

Mount Sinai Health System and Renalytix Form Joint Venture, Kantaro Biosciences, To Develop and Scale Production of COVID Antibody Test Kits

Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course

"New Blood Tests For Antibodies Could Show True Scale Of Coronavirus Pandemic" - Gretchen Vogel

Prior Dengue Virus Infection May Cause Severe Outcomes Following Zika Virus Infection During Pregnancy, Mount Sinai Study Shows